Clinical Trials on Mental Disease

Total 408401 results

Christiana Care Health Services

Terminated

Arch Bars vs. IMF (Intermaxillary Fixation) Screws: Cost Effectiveness Based on Time Duration of Device Placement.

Mandible Fracture

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without Sargramostim

Melanoma (Skin)
McGill University Health Centre/Research Institute...

Unknown

Safety and Feasibility of Early Active Rehabilitation in Children After Concussion

Concussion | Post-Concussion Symptoms

Canada
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma

Melanoma (Skin)

United States
University of Miami

Completed

Pegylated Arginine Deiminase in Treating Patients With Metastatic Melanoma That Cannot Be Removed by Surgery

Melanoma (Skin)

United States
GERCOR - Multidisciplinary Oncology Cooperative...
Pfizer; Ipsen

Unknown

A Study of Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid Tumors (SUNLAND)

Carcinoid Tumors

France, Belgium
Centre Hospitalier Universitaire de Nīmes

Completed

Human Papillomavirus and Rate of Pregnancy Achieved Via Medically Assisted Procreation (PAPILLO-PMA)

Infertility | Papillomavirus Infections | Sub-fertility

France
Boehringer Ingelheim

Completed

BIBW 2992 (Afatinib) in Head & Neck Cancer

Head and Neck Neoplasms | Carcinoma, Squamous Cell

United States, Belgium, France, Spain
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Everolimus in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

United States
University of Tennessee Health Science Center
Regional One Health

Unknown

Antenatal Testing in Obese Woman, is it Really Necessary? (ATOWS)

Obesity in Pregnancy
Hospices Civils de Lyon

Unknown

Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS) (IMMUNOSEPSIS)

Immunology of Septic Shock

France
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma

Melanoma (Skin)

United States
Vanderbilt-Ingram Cancer Center

Completed

68Ga-DOTATATE PET Scan in Neuroendocrine Cancer (68Ga)

Neuroendocrine Carcinoma

United States
Amgen

No longer available

Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma

Unresected Stage IIIb to IVM1c Melanoma

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
University Hospital Erlangen

Completed

Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma

Melanoma (Skin)

Germany
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group; Children... and other collaborators

Completed

S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma

Melanoma (Skin)

United States, Australia
University of Virginia
National Cancer Institute (NCI)

Completed

Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
Philogen S.p.A.

Completed

Intratumoral Application of L19IL2 in Patients With Malignant Melanoma

Malignant Melanoma

Austria, Germany
University of Virginia
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
Aeras
Statens Serum Institut

Completed

A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS-404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection

Tuberculosis

Sweden
Hoag Memorial Hospital Presbyterian

Completed

Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma

Melanoma (Skin)

United States
Blumenthal Cancer Center at Carolinas Medical Center

Unknown

Interleukin-2 in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma

Melanoma (Skin)

United States
Herbert Irving Comprehensive Cancer Center
National Cancer Institute (NCI)

Unknown

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
Herbert Irving Comprehensive Cancer Center
National Cancer Institute (NCI)

Unknown

Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma

Melanoma (Skin)

United States
St. Luke's Medical Center

Unknown

Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
University of Chicago
National Cancer Institute (NCI)

Completed

Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
Leeds Cancer Centre at St. James's University Hospital

Unknown

Answering Questions About Vitamin D Supplementation and Sun Exposure in Patients Who Have Undergone Surgery for Stage IB, Stage II, or Stage IIIA Melanoma

Melanoma (Skin)

United Kingdom
Cambridge University Hospitals NHS Foundation Trust

Completed

Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery

Melanoma (Skin)

United Kingdom
Gynecologic Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Completed

Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus

Sarcoma

United States
Baylor Health Care System
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Completed

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Melanoma

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Terminated

Cilengitide in Treating Patients With Unresectable or Metastatic Melanoma

Stage IV Melanoma | Stage III Melanoma

United States
NCIC Clinical Trials Group
National Cancer Institute (NCI)

Completed

SB-715992 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Melanoma (Skin)

Canada
Maastricht University Medical Center

Completed

Borderzone Sampling (BZS)

Glioblastoma | High Grade Glioma

Netherlands
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
Duke University
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal

Melanoma (Skin)

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma

Melanoma (Skin)

United States
Infinity Pharmaceuticals, Inc.

Terminated

A Study Evaluating the Safety and Antitumor Activity of IPI-504, in Patients With Metastatic Melanoma

Metastatic Melanoma

United States
Northwell Health

Completed

Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?

HIV Infections | Latent Tuberculosis

United States
Centre Georges Francois Leclerc
Pfizer; Hoffmann-La Roche; National Cancer Institute, France; UNICANCER; Association...

Completed

Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma (TemAvIr)

Naive Unresectable Glioblastoma

France
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

United States
European Organisation for Research and Treatment...

Completed

E7070 in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

France, Switzerland, Norway, Belgium, United Kingdom, Germany, Austria, Portugal, Italy
Mannkind Corporation

Completed

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

United States
European Organisation for Research and Treatment...

Completed

Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

France, Switzerland, Germany, Belgium, Netherlands, United Kingdom, Italy, Portugal, Austria

Clinical Trials on Mental Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations